Managing discovery in the life sciences : (Record no. 39291)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | nam a22 7a 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 190320b2018 xxu||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9781107577305 |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 610.72 REA-P |
100 ## - MAIN ENTRY--PERSONAL NAME | |
Personal name | Rea, Philip A. |
245 ## - TITLE STATEMENT | |
Title | Managing discovery in the life sciences : |
Remainder of title | harnessing creativity to drive biomedical innovation / |
Statement of responsibility, etc. | Philip A. Rea, Mark V. Pauly and Lawton R. Burns |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
Place of publication, distribution, etc. | United Kingdom |
Name of publisher, distributor, etc. | Cambridge University Press |
Date of publication, distribution, etc. | 2018 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 542 p. |
365 ## - TRADE PRICE | |
Price type code | GBP |
Price amount | 29.99. |
500 ## - GENERAL NOTE | |
General note | In this book, distinguished scholars Philip A. Rea, Mark V. Pauly, and Lawton R. Burns explore the science and management behind marketable biomedical innovations. They look at how the science actually played out through the interplay of personalities, the cultures within and between academic and corporate entities, and the significance of serendipity not as a mysterious phenomenon but one intrinsic to the successes and failures of the experimental approach. With newly aggregated data and case studies, they consider the fundamental economic underpinnings of investor-driven discovery management, not as an obstacle or deficiency as its critics would contend or as something beyond reproach as some of its proponents might claim, but as the only means by which scientists and managers can navigate the unknowable to discover new products and decide how to sell them so as to maximize the likelihood of establishing a sustainable pipeline for still more marketable biomedical innovations. |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Medical sciences--Research |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Medicine--Research |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pauly, Mark V. |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Burns, Lawton R. |
952 ## - LOCATION AND ITEM INFORMATION (KOHA) | |
Withdrawn status |
Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection code | Home library | Current library | Shelving location | Date acquired | Cost, normal purchase price | Total Checkouts | Full call number | Barcode | Date last seen | Date last checked out | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dewey Decimal Classification | 610 | BITS Pilani Hyderabad | BITS Pilani Hyderabad | General Stack (For lending) | 20/03/2019 | 29.99 | 1 | 610.72 REA-P | 37616 | 13/07/2024 | 05/05/2019 | 20/03/2019 | Books |